Crossmark

Vidarabine, an anti-herpes agent, improves Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in mice

Crossref DOI link: https://doi.org/10.1186/s12576-023-00873-5

Published Print: 2023

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tsunoda, Michinori

Matsuo, Ichiro

Ohnuki, Yoshiki

Suita, Kenji

Ishikawa, Misao

Mitsubayashi, Takao

Ito, Aiko

Mototani, Yasumasa

Kiyomoto, Kenichi

Morii, Akinaka

Nariyama, Megumi

Hayakawa, Yoshio

Gomi, Kazuhiro

Okumura, Satoshi https://orcid.org/0000-0001-8747-7941
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (22K21003)

Japan Society for the Promotion of Science (20K10304)

Japan Society for the Promotion of Science (20K10305)

Japan Society for the Promotion of Science (19K24109)

Japan Society for the Promotion of Science (21K17171)

Japan Society for the Promotion of Science (22K10255)

Japan Society for the Promotion of Science (21K10242)
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-08-09
More Information

This article is maintained by: Elsevier

Article Title: Vidarabine, an anti-herpes agent, improves Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in mice

Journal Title: The Journal of Physiological Sciences

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s12576-023-00873-5

Content Type: article

Copyright: Copyright © 2023 The Author(s). Published by Elsevier Inc.